103 related articles for article (PubMed ID: 3469446)
1. [Tumor markers in the field of obstetrics and gynecology].
Mochizuki M
Rinsho Byori; 1986 Nov; 34(11):1274-83. PubMed ID: 3469446
[No Abstract] [Full Text] [Related]
2. Tumor markers for the diagnosis, prognosis, treatment and follow-up of gynaecological tumors.
Ulsperger E; Karrer K
Suppl J Med Oncol Tumor Pharmacother; 1988; 1():33-43. PubMed ID: 3074225
[No Abstract] [Full Text] [Related]
3. [Serum CA 125 and TPA determination in malignant neoplasms of the uterus].
Gadducci A; Facchini V; Bartolini T; Fioretti P
Ann Ostet Ginecol Med Perinat; 1988; 109(3):151-5. PubMed ID: 3207319
[No Abstract] [Full Text] [Related]
4. [Gynecologic malignancies].
Kato H
Nihon Rinsho; 1996 Jun; 54(6):1637-41. PubMed ID: 8691622
[TBL] [Abstract][Full Text] [Related]
5. [Serum levels of the CA-125 antigen in the diagnosis of ovarian neoplasms].
Sopracordevole F; Finco B; Scarabelli C; Campagnutta E; Alimena C; Perin A
Minerva Ginecol; 1985 Oct; 37(10):589-96. PubMed ID: 3866146
[No Abstract] [Full Text] [Related]
6. [A case of hCG-producing cervical carcinoma of uterus].
Ohara A; Yamada S; Suzuki N; Okagaki A; Shibamoto T; Nagano T; Nakai Y; Ban C; Tamura H; Suzuki A
Nihon Sanka Fujinka Gakkai Zasshi; 1993 Nov; 45(11):1333-6. PubMed ID: 8258734
[No Abstract] [Full Text] [Related]
7. [Diagnostic significance of tumor markers for gynecologic malignancies].
Aoki D; Hirasawa A; Susumu N
Gan To Kagaku Ryoho; 2005 Mar; 32(3):411-6. PubMed ID: 15791829
[TBL] [Abstract][Full Text] [Related]
8. Uterine tumors.
Kato H
Immunol Ser; 1990; 53():385-95. PubMed ID: 2100568
[No Abstract] [Full Text] [Related]
9. Cancer chemotherapy based on the measurement of a tumor specific antigen.
Goldstein DP; Nudemberg F; Shirley RL
Surg Forum; 1971; 22():390-2. PubMed ID: 4330603
[No Abstract] [Full Text] [Related]
10. [Case report on choriocarcinoma].
Richter P; Schollberg K
Zentralbl Gynakol; 1978; 100(2):110-14. PubMed ID: 565572
[No Abstract] [Full Text] [Related]
11. Biochemical and immunologic diagnosis of cancer. Ovarian cancer.
Stenman UH; Seppälä M
Tumour Biol; 1987; 8(2-3):109-12. PubMed ID: 2834812
[No Abstract] [Full Text] [Related]
12. Coexisting choriocarcinoma with breast cancer: a hazard or an association?
Ben Temime R; Ben Hassouna J; Attia L; Mathlouthi N; Makhlouf T; Koubaa A; Mezlini A; Rahal K; Chachia A
Tunis Med; 2010 Oct; 88(10):771-2. PubMed ID: 20890833
[No Abstract] [Full Text] [Related]
13. [Practice of diagnosis of chorionic tumor].
Adachi Y; Kurachi K; Iijima H; Yasawa T; Okudaira Y
Sanfujinka No Jissai; 1970 Sep; 19(9):962-76. PubMed ID: 5468858
[No Abstract] [Full Text] [Related]
14. [Choriocarcinoma: an exceptional tumor].
Steffelaar JW
Ned Tijdschr Geneeskd; 1981 May; 125(18):689-94. PubMed ID: 7194968
[No Abstract] [Full Text] [Related]
15. [On the problem of chorionepithelioma].
Rauter B
Wien Klin Wochenschr; 1968 Aug; 80(33):634-6. PubMed ID: 5692999
[No Abstract] [Full Text] [Related]
16. Hydatidiform mole. A follow-up regimen for identification of invasive mole and choriocarcinoma and for selection of patients for treatment.
Brewer JI; Torok EE; Webster A; Dolkart RE
Am J Obstet Gynecol; 1968 Jun; 101(4):557-63. PubMed ID: 5690298
[No Abstract] [Full Text] [Related]
17. [Tumor markers and their significance in gynecologic oncology].
Melchert F; Kreienberg R
Gynakologe; 1980 Jun; 13(2):74-88. PubMed ID: 6299910
[No Abstract] [Full Text] [Related]
18. [A case of primary gestational ovarian choriocarcinoma].
Maehama T; Uemura S; Higashi M; Kanazawa K; Unten K
Nihon Sanka Fujinka Gakkai Zasshi; 1996 Jun; 48(6):427-30. PubMed ID: 8752705
[No Abstract] [Full Text] [Related]
19. [Incidence of CA 125 antigen in the blood of women with ovarian carcinoma].
Tosner J; Lacinová V; Louda B; Vanásek J
Cesk Gynekol; 1987 Nov; 52(9):681-4. PubMed ID: 3482173
[No Abstract] [Full Text] [Related]
20. Limitations of tumour markers in screening.
Roulston JE
Br J Surg; 1990 Sep; 77(9):961-2. PubMed ID: 2095760
[No Abstract] [Full Text] [Related]
[Next] [New Search]
